Trends in Oncology: A Focus on Medical Pharmacy Spend by Magellan Rx Management October 26, 2020Biosimilars, Magellan Health, Magellan RX, Magellan Rx Management, Medical Pharmacy, Medical Pharmacy Spend, Medical Pharmacy Trend Report, Oncology, Oncology Biosimilars, Oncology Spend, Pharmacy Trends, Specialty Spend
The Future of Holistic Oncology Management by Rebecca Borgert October 30, 2019Biosimilairs, Cancer Care, Holistic Oncology Management, Magellan Health, Magellan Healthcare, Magellan RX, Oncology
3 Key Trends to Consider for Oncology Management by Rebecca Borgert June 5, 2019Cancer, Cancer treatment, FDA, Magellan, Magellan Health, Magellan Healthcare, Magellan RX, Magellan Rx Management, Medical Benefit Drug Management, Medical Oncology Spend, Novel Cancer Drugs, Oncology, Oncology Biosimilars, Oncology Management
What do Employers Need to Know about Escalating Specialty Drug Spend? by Kathy Campagna May 24, 2017Autoimmune, Employers, Magellan Rx Management, Medical Benefit, Oncology, PBM, Rare Diseases, Specialty Pharmacy
Six Ways to Keep Specialty Spend Under Control by Magellan Health Insights March 31, 2017Magellan Rx Management, Matt Ward, Medical Pharmacy, Oncology, PBM, Pharmacy Benefits Management, Specialty Pharmacy
A Value-Based PBM: Implications for Various Stakeholders by Magellan Health Insights October 13, 2016Dr. Karen Amstutz, Dr. Maria Lopes, Magellan Health, Magellan Rx Management, Oncology, PBM, Pharmacy, Pharmacy Benefit Management, Specialty Pharmacy, Value-Based
